Galderma / Q-Med AB
Restylane
A family of hyaluronic acid fillers whose individual products have distinct formulations, properties, and approved treatment areas.
Hyaluronic acid dermal filler familyReviewed 7/30/2026Source recorded
At a glance
| Primary purpose | Product-specific augmentation or correction of lips, folds, cheeks, chin, temples, infraorbital hollowing, and dorsal hands. |
|---|---|
| Mechanism | Cross-linked hyaluronic acid gel adds physical volume; formulation technology, gel properties, lidocaine content, intended tissue plane, and area differ by product. |
| When results appear | Immediate gel volume, with final assessment after early swelling settles. |
| Typical sessions | Usually one visit per area with possible staged treatment or touch-up. |
| Downtime | Typically limited, but swelling, bruising, pain, tenderness, redness, and lumps can occur. |
| Longevity | Varies by exact Restylane product, area, amount, and patient; no family-wide duration is assigned. |
| Reversibility | The HA gel may often be reduced with off-label hyaluronidase, with product-dependent and incomplete response possible. |
| Documented risks | Injection-site reactions, nodules, infection, inflammatory reactions, and rare intravascular injection causing necrosis, vision loss, or stroke. |
| Most common disappointment | A family-level comparison can hide clinically important product and treatment-area differences. |
| Common marketing misconception | Restylane is a portfolio, not a single filler. |
| What varies by provider | Specific product, total volume, anatomy, plane, needle or cannula, and complication preparedness. |
| When this treatment may not be appropriate | When filler contraindications apply, the intended area lacks an appropriate product, or the concern is muscular, textural, or surgical rather than volumetric. |
| United States regulatory status | Restylane devices are FDA-approved through product-specific PMAs and supplements; each product retains its own indication. |
| Canadian regulatory status | Health Canada MDALL lists active Class III Restylane licences, including product-specific records such as Restylane Kysse; exact licensed intended use must be checked. |
| Evidence status | High for family composition, safety framework, and product-specific regulation; no family-wide superiority or duration claim is made. |
Sources
- Explore Restylane Products and Treatment Areasofficial manufacturer safety information · manufacturer-primary · supports 22 profile fields
- FDA PMA P040024: RestylaneFDA PMA record · regulatory-primary · supports 2 profile fields
- Health Canada MDALL: Q-Med Restylane licencesHealth Canada MDALL · regulatory-primary
- Restylane Science and Technologyofficial manufacturer information · manufacturer-primary
Related comparisons
See average treatment prices near you
Enter a US ZIP code or Canadian postal code to check our stored estimate for the surrounding market.